Replies to post #947 on Precious Metals

[gfp927z]

Thanks, MYMX does look interesting from a science perspective, though financially not so great, with only $1.5 mil in cash, $47 mil in debt, and a bloated share count up over 300 mil shares (per Yahoo). Only losing $3 mil per year though, which isn't too bad for a micro cap biotech.

I'll check them out further. Having Sanofi interest is a good sign, though I see the RSV program was dropped by Astellas.

But with vaccines there is a whole other side. Besides being money makers for big pharma, they are an integral part of the NWO population control agenda. This is not some wild conspiracy theory, but is admitted to by some of the big players (UN Agenda 21) if you read their documents.

Novel vaccine approaches share the same problem as breakthrough antibiotic technologies (defensin mimetics for example - CTIX), their adoption can result in a big increase in world population. So when this type of technology actually works it can end up being stonewalled or 'deep sixed' by the powers that be -